Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 7 hours ago
Human medicines European public assessment report (EPAR): Loqtorzi, toripalimab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Loqtorzi, toripalimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Silapo, epoetin zeta, Date of authorisation: 18/12/2007, Revision: 18, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Silapo, epoetin zeta, Date of...
Human medicines European public assessment report (EPAR): Elmiron, pentosan polysulfate sodium, Date of authorisation: 02/06/2017, Revision: 15, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Elmiron, pentosan polysulfate sodium, Date...
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Dzuveo, sufentanil, Date of authorisation: 25/06/2018, Revision: 9, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Dzuveo, sufentanil, Date of authorisation...
Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously Vyxeos), daunorubicin,cytarabine, Date of authorisation: 23/08/2018, Revision: 11, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously Vyxeos), daunorubicin,cytarabine...
Silapo : EPAR - All Authorised presentations
about 22 hours ago
Silapo : EPAR - All Authorised presentations
Orphan designation: tobevibart Treatment of hepatitis delta virus infection, 13/12/2024 Positive
about 8 hours ago
Orphan designation: tobevibart Treatment of hepatitis delta virus infection, 13/12/2024 Positive
Orphan designation: Measles virus Schwarz strain (live, attenuated) Treatment of mesothelioma, 23/02/2026 Positive
about 8 hours ago
Orphan designation: Measles virus Schwarz strain (live, attenuated) Treatment of mesothelioma, 23/02/2026...
Orphan designation: recombinant human surfactant protein D Prevention of bronchopulmonary dysplasia, 11/04/2014 Positive
about 13 hours ago
Orphan designation: recombinant human surfactant protein D Prevention of bronchopulmonary dysplasia, 11/04/2014...
Orphan designation: mRNA encoding Cas12HF endonuclease, Single guide RNA against the human HAO1 gene Treatment of primary hyperoxaluria, 22/08/2025 Positive
about 8 hours ago
Orphan designation: mRNA encoding Cas12HF endonuclease, Single guide RNA against the human...